Javascript must be enabled to continue!
Characterization of the immature secretory granule, an intermediate in granule biogenesis.
View through CrossRef
The events in the biogenesis of secretory granules after the budding of a dense-cored vesicle from the trans-Golgi network (TGN) were investigated in the neuroendocrine cell line PC12, using sulfate-labeled secretogranin II as a marker. The TGN-derived dense-cored vesicles, which we refer to as immature secretory granules, were found to be obligatory organellar intermediates in the biogenesis of the mature secretory granules which accumulate in the cell. Immature secretory granules were converted to mature secretory granules with a half-time of approximately 45 min. This conversion entailed an increase in their size, implying that the maturation of secretory granules includes a fusion event involving immature secretory granules. Pulse-chase labelling of PC12 cells followed by stimulation with high K+, which causes the release of secretogranin II, showed that not only mature, but also immature secretory granules were capable of undergoing regulated exocytosis. The kinetics of secretion of secretogranin II, as well as those of a constitutively secreted heparan sulfate proteoglycan, were reduced by treatment of PC12 cells with nocodazole, suggesting that both secretory granules and constitutive secretory vesicles are transported to the plasma membrane along microtubules. Our results imply that certain membrane proteins, e.g., those involved in the fusion of post-TGN vesicles with the plasma membrane, are sorted upon exit from the TGN, whereas other membrane proteins, e.g., those involved in the interaction of post-TGN vesicles with the cytoskeleton, may not be sorted.
Rockefeller University Press
Title: Characterization of the immature secretory granule, an intermediate in granule biogenesis.
Description:
The events in the biogenesis of secretory granules after the budding of a dense-cored vesicle from the trans-Golgi network (TGN) were investigated in the neuroendocrine cell line PC12, using sulfate-labeled secretogranin II as a marker.
The TGN-derived dense-cored vesicles, which we refer to as immature secretory granules, were found to be obligatory organellar intermediates in the biogenesis of the mature secretory granules which accumulate in the cell.
Immature secretory granules were converted to mature secretory granules with a half-time of approximately 45 min.
This conversion entailed an increase in their size, implying that the maturation of secretory granules includes a fusion event involving immature secretory granules.
Pulse-chase labelling of PC12 cells followed by stimulation with high K+, which causes the release of secretogranin II, showed that not only mature, but also immature secretory granules were capable of undergoing regulated exocytosis.
The kinetics of secretion of secretogranin II, as well as those of a constitutively secreted heparan sulfate proteoglycan, were reduced by treatment of PC12 cells with nocodazole, suggesting that both secretory granules and constitutive secretory vesicles are transported to the plasma membrane along microtubules.
Our results imply that certain membrane proteins, e.
g.
, those involved in the fusion of post-TGN vesicles with the plasma membrane, are sorted upon exit from the TGN, whereas other membrane proteins, e.
g.
, those involved in the interaction of post-TGN vesicles with the cytoskeleton, may not be sorted.
Related Results
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract
Introduction
Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Secretory Mammary Carcinoma In Situ in a Cat
Secretory Mammary Carcinoma In Situ in a Cat
Background: Secretory carcinoma is a rare mammary neoplasm observed in humans and animals. It was 1st called juvenile carcinoma. Secretory carcinoma is characterized by eosinophili...
Abstract 1697: Pharmacological inhibition of ATM results in mitochondrial biogenesis in AMPK independent manner.
Abstract 1697: Pharmacological inhibition of ATM results in mitochondrial biogenesis in AMPK independent manner.
Abstract
The gene mutated in Ataxia telangiectasia termed Ataxia Telangiectasia Mutated (ATM) encodes for a Serine/Threonine protein kinase which functions at the co...
Astroglia proliferate upon biogenesis of tunneling nanotubes and clearance of α-synuclein toxicities
Astroglia proliferate upon biogenesis of tunneling nanotubes and clearance of α-synuclein toxicities
Abstract
Astrocytic cells are a subtype of glial cells that engulf pathogenic aggregates derived from degenerative neurons to facilitate its degradation. Here, we s...
More Than Reels: Cajal-Retzius Cells Become Active
More Than Reels: Cajal-Retzius Cells Become Active
Granule Cell Dispersion in Two Mouse Models of Temporal Lobe Epilepsy and Reeler Mice Is Associated With Changes in Dendritic Orientation and Spine Distribution
...
Trifluoperazine causes mast cell apoptosis through a secretory granule-mediated pathway
Trifluoperazine causes mast cell apoptosis through a secretory granule-mediated pathway
Abstract
Mast cells contribute to the pathology of various diseases, in particular allergic conditions. Therefore, it is essential to develop strategies that effi...
Morpho–anatomical and ultrastructural analysis of extrafloral nectaries in
Inga edulis
(Vell.) Mart. (Leguminosae)
Morpho–anatomical and ultrastructural analysis of extrafloral nectaries in
Inga edulis
(Vell.) Mart. (Leguminosae)
The presence of extrafloral nectaries (EFNs) between leaflets is an usual feature in
Inga edulis
(Vell.) Mart. (Leguminosae). Extrafloral ne...
Compound Shenma Jingfu granule alleviates cerebral ischemia via HIF-1α-mediated promotion of angiogenesis
Compound Shenma Jingfu granule alleviates cerebral ischemia via HIF-1α-mediated promotion of angiogenesis
Abstract
Background
Shenma Jingfu Granule, a traditional Chinese medicine formula, has been used clinically for the treatment of cerebral circulatio...

